(Press-News.org) Moderate alcohol consumption increases the risk of atrial fibrillation in older people with heart disease or advanced diabetes, found a study in CMAJ (Canadian Medical Association Journal).
"Moderate to high alcohol intake was associated with an increased incidence of atrial fibrillation among people aged 55 or older with cardiovascular disease or diabetes," writes Dr. Koon Teo, McMaster University, Hamilton, Ontario, with coauthors. "Among moderate drinkers, the effect of binge drinking on the risk of atrial fibrillation was similar to that of habitual heavy drinking."
The findings come from a large study involving more than 30 000 individuals aged 55 years or older from 40 countries who had a history of cardiovascular disease or advanced diabetes with organ damage. Data came from the ONTARGET or TRANSCEND trials, which enrolled people between November 2001 and May 2004 with a follow up period of 56 months. The mean age of participants was 66.4 years and 29.8% (9064) were women. Of the participants, 61.7% were classified as having low alcohol consumption (up to 1 drink per week), 36.6% moderate and 1.7% high (more than 2 drinks a day for women and more than 3 for men).
Moderate alcohol consumption was defined using the World Health Organization's (WHO) recommended consumption levels of up to 2 drinks a day — or 1 to 14 drinks a week for women — and up to 3 drinks a day — or 1 to 21 drinks a week — for men. Binge drinking was classified as 5 or more drinks a day, regardless of whether someone was usually a low-, moderate- or high-level alcohol consumer.
Almost 79% of binge drinkers in the study (948 of 1204) fell into the moderate-consumption group.
There were 2093 new cases of atrial fibrillation during the follow-up period. The age- and sex-standardized incidence rate per 1000 person-years was 14.5 in the low-intake group, 17.3 in the moderate-intake group and 20.8 in the high-intake group. The increase in atrial fibrillation cases linked to higher alcohol consumption was found in each age group.
"Because drinking moderate quantities of alcohol was common in our study (36.6% of the participants), our findings suggest that the effect of increased alcohol consumption, even in moderate amounts, on the risk of atrial fibrillation among patients with existing cardiovascular disease may be considerable," state the authors.
Limited data from other studies indicates that binge drinking in healthy people may increase the risk of atrial fibrillation, although moderate drinking in healthy individuals does not appear to be linked to increased risk.
"Recommendations about the protective effects of moderate alcohol intake in patients at high risk of cardiovascular disease may need to be tempered with these findings," the authors conclude.
### END
Moderate alcohol consumption may increase risk of atrial fibrillation in people with heart disease
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Poor sleep in adolescents may increase risk of heart disease
2012-10-01
Adolescents who sleep poorly may be at risk of cardiovascular disease in later life, according to a study in CMAJ (Canadian Medical Association Journal).
"We found an association between sleep disturbance and cardiovascular risk in adolescents, as determined by high cholesterol levels, increased BMI [body mass index] and hypertension," writes lead author Dr. Indra Narang, respirologist and director of sleep medicine at The Hospital for Sick Children (SickKids), Toronto, Ontario, with coauthors. "These findings are important, given that sleep disturbance is highly prevalent ...
National study finds reduced glaucoma risk in patients who take statins
2012-10-01
SAN FRANCISCO – October 1, 2012 – People who take statins to reduce their risk of cardiovascular disease are less likely to be diagnosed with the most common form of glaucoma, according to a nationwide study of more than 300,000 patients. A University of Michigan School of Medicine research team, directed by Joshua Stein, MD, MS, found that the risk for glaucoma was reduced by eight percent in patients who took statins continuously for two years, compared with patients who did not take statins. The study, the largest to date on the topic, is published in the October issue ...
Overweight teens get mental health boost from even small amounts of exercise
2012-10-01
OTTAWA, Canada – October 1, 2012 – Being obese at any age is commonly associated with a litany of health issues, ranging from diabetes and chronic fatigue to heart complications. Overweight adolescents are also at an increased risk of body dissatisfaction, social alienation and low self esteem, which is why Dr. Gary Goldfield, registered psychologist, clinical researcher at the Children's Hospital of Eastern Ontario (CHEO) Research Institute, and Associate Professor in the Department of Pediatrics, University of Ottawa, set out to discover how exercise might impact these ...
Genetics Society of America's GENETICS journal highlights for October 2012
2012-10-01
Bethesda, MD—October 1, 2012 – Listed below are the selected highlights for the October 2012 issue of the Genetics Society of America's journal, GENETICS. The October issue is available online at www.genetics.org/content/current. Please credit GENETICS, Vol. 192, October 2012, Copyright © 2012.
Please feel free to forward to colleagues who may be interested in these articles.
ISSUE HIGHLIGHTS
Energy-dependent modulation of glucagon-like signaling in Drosophila via the AMP-activated protein kinase, pp. 457
Jason T. Braco, Emily L. Gillespie, Gregory E. Alberto, ...
Evolutionary analysis improves ability to predict the spread of flu
2012-10-01
BETHESDA, MD – October 1, 2012 – With flu season around the corner, getting a seasonal vaccine might be one of the best ways to prevent people from getting sick. These vaccines only work, however, if their developers have accurately predicted which strains of the virus are likely to be active in the coming season because vaccines must be developed in advance of the upcoming flu season. Recently, a team of scientists from Germany and the United Kingdom have improved the prediction methods used to determine which strains of the flu virus to include in the current season's ...
First large scale trial of whole-genome cancer testing for clinical decision-making reported
2012-10-01
VIENNA, Austria, 1 October 2012 – For the first time, researchers have conducted a large trial in which they tested the entire genome of individual breast cancers to help personalize treatment. They released their findings at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
In recent years, a number of drugs have been developed that target specific genetic alterations in cancer. To choose which of these drugs are suitable for individual patients, some genetic testing is performed. "In most of these cases, these genetic testing approaches ...
New findings on optimal duration of trastuzumab therapy for women with HER2+ early breast cancer
2012-10-01
VIENNA, Austria, 1 October 2012 – New studies that advance understanding of the optimal duration of therapy with the targeted cancer drug trastuzumab were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
"These long awaited results constitute a further milestone in the treatment of patients with early breast cancer over-expressing HER2/neu, corresponding to a population of about 12-15% of all cases of breast cancer," commented Prof Christoph Zielinski, Chairman of the Clinical Division of Oncology, at Medical University ...
Phase III data in treatment of renal cell carcinoma reported
2012-10-01
Vienna, Austria, 1 October 2012 – New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Renal cell carcinoma is a type of kidney cancer that starts in the lining of very small tubes (tubules) in the kidney.
Prof Maria De Santis from Kaiser Franz Josef-Spital, Vienna, Chair of the ESMO 2012 Genitourinary program track (who was not involved in the studies) commented: "At this year's ESMO congress, three urgently awaited ...
New findings highlight the challenges of managing blood clotting in cancer patients
2012-10-01
VIENNA, Austria, 1 October 2012 – New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Venous thromboembolism causes symptoms in about 3 to 4% of cancer patients whose chemotherapy drugs are delivered via a central venous catheter, comments Dr. Fausto Roila, from Medical Oncology Department, Terni, Italy, Chair of the ESMO 2012 Supportive Care Track. "When asymptomatic patients are considered, these events affect ...
Should aspirin be used to prevent cancer?
2012-10-01
VIENNA, Austria, 1 October 2012 – Aspirin, the everyday drug taken by countless people around the world to ward off pain and reduce their risk of developing heart disease, may have a new trick up its sleeve –-preventing cancer.
A growing body of evidence suggests that taking aspirin may reduce an individual's chances of developing colorectal cancer and perhaps other malignancies, but whether that evidence is strong enough to outweigh the risks of prescribing it to millions of healthy people is the subject of debate.
At the ESMO 2012 Congress in Vienna, both sides of ...